To identify Chlamydia trachomatis genes involved in attachment to host cells, a chlamydial genomic library was screened on the basis of binding characteristics by two methods. In the whole-cell screen, individual recombinant Escherichia coli clones were assayed for adherence to eukaryotic cells. In the membrane-binding screen, each recombinant colony of E. coli was treated with CHCI3 and assayed for binding to purified, 3-[(3-cholamidopropyl) Maxicell analysis of selected recombinants confirmed that the proteins of 28 and -82 kDa, and perhaps of 18 kDa, are plasmid encoded. Antiserum generated against the recombinant -82-kDa protein reacted in Western analysis with a similar-sized protein from C. trachomatis serovar E elementary bodies (EB) and reticulate bodies, serovar L2 EB, and C. psittaci EB. E. coli JM109(pPBW58) contains a 6.7-kb plasmid insert which encodes proteins of all three sizes. Under a number of different conditions in the whole-cell attachment assay-i.e., at 4°C, in Ca2+-and Mg2+-free medium, in the presence of trypsin or dextran sulfate, and with rabbit aortic endothelial cells-the binding specificity of JM109(pPBW58) parallels that of C. trachomatis EB. Finally, the adherence phenotype of E. coli JM109(pPBW58) correlates directly with the presence of the recombinant plasmid; the phenotype is lost concurrently with loss of the recombinant plasmid, and the phenotype is acquired concurrent with reintroduction of the recombinant plasmid into E. coli JM109. The role of the 18-, 28-, and -82-kDa proteins in mediating attachment, whether they act in concert as a complex or individually, has yet to be determined.
To identify Chlamydia trachomatis genes involved in attachment to host cells, a chlamydial genomic library was screened on the basis of binding characteristics by two methods. In the whole-cell screen, individual recombinant Escherichia coli clones were assayed for adherence to eukaryotic cells. In the membrane-binding screen, each recombinant colony of E. coli was treated with CHCI3 and assayed for binding to purified, 3-[(3-cholamidopropyl)-dimethyl-ammonio]-1-propanesulfonate (CHAPS)-solubilized, 35S-labeled eukaryotic membrane material. Initial screening with McCoy ceUs was refined by using HEC-1B cells, a human endometrial epithelial cell line, which discriminate among recombinants adhering to McCoy cells. Some recombinants demonstrate significantly greater adherence to HEC-1B cells than to McCoy cells and appear, by transmission electron microscopy, to associate with electron-dense areas of the epithelial cell plasma membrane, resembling coated pits. Recombinants positive by one or both screening methods were examined by Southern and Western (immunoblot) analyses, which revealed the presence of chlamydial sequences inserted in the plasmids and the expression of novel 18-, 28-, and -82-kDa proteins, recognized by antichlamydial sera. Maxicell analysis of selected recombinants confirmed that the proteins of 28 and -82 kDa, and perhaps of 18 kDa, are plasmid encoded. Antiserum generated against the recombinant -82-kDa protein reacted in Western analysis with a similar-sized protein from C. trachomatis serovar E elementary bodies (EB) and reticulate bodies, serovar L2 EB, and C. psittaci EB. E. coli JM109(pPBW58) contains a 6.7-kb plasmid insert which encodes proteins of all three sizes. Under a number of different conditions in the whole-cell attachment assay-i.e., at 4°C, in Ca2+-and Mg2+-free medium, in the presence of trypsin or dextran sulfate, and with rabbit aortic endothelial cells-the binding specificity of JM109(pPBW58) parallels that of C. trachomatis EB. Finally, the adherence phenotype of E. coli JM109(pPBW58) correlates directly with the presence of the recombinant plasmid; the phenotype is lost concurrently with loss of the recombinant plasmid, and the phenotype is acquired concurrent with reintroduction of the recombinant plasmid into E. coli JM109. The role of the 18-, 28-, and -82-kDa proteins in mediating attachment, whether they act in concert as a complex or individually, has yet to be determined.
In nature, the obligate intracellular bacterium Chlamydia trachomatis demonstrates selectivity in the host organism (humans) and the types of host cells infected. C. trachomatis serovars A, B, Ba, and C infect conjunctival epithelia; serovars D through K primarily infect urogenital epithelia, though conjunctival and fetal bronchial epithelia are also susceptible. The lymphogranuloma venereum biovar (C. trachomatis serovars Li, L2, and L3) initially infects the urogenital epithelial but then invades deeper tissue, demonstrating a marked lymphotrophism. Cell selectivity in vivo has a number of plausible explanations, which include restriction to cell types to which the nonmotile, infectious C. trachomatis elementary bodies (EB) are exposed, and restriction to cell types capable of supporting chlamydial growth (30) . Selective adherence only to cells capable of supporting growth is more economical, and certainly, as the processes of attachment and entry are of vital importance, one might suppose that chlamydiae have evolved a strategy to ensure their entry into the appropriate host cell.
Adherence and entry of Chlamydia spp. have been studied by numerous investigators, and some findings suggest that 4002 SCHMIEL ET AL. tivity of some serovars of C. trachomatis and that Ca2" or Mg2+ is necessary for maximal adherence (14, 25) . Since both the eukaryotic cell surface and chlamydiae carry a net negative charge, a formidable electrostatic barrier must be overcome prior to attachment (39, 47) . Indeed, in an elegant study by Su et al. (44) , the major outer membrane protein (MOMP) is proposed to promote localized, nonspecific electrostatic and hydrophobic interactions with the host cell. They demonstrated that monoclonal antibodies to MOMP surface-exposed epitopes in variable domains II and IV block EB attachment to hamster kidney cells (43, 44 (ii) In the event that chlamydial proteins expressed in the recombinant could not be properly exported to and folded on the surface of E. coli, chloroform-exposed colonies of each recombinant were assayed for eukaryotic membrane-binding activity by incubation with 35S-labeled eukaryotic membrane. Several recombinants that were positive by one or both methods are indeed producing novel proteins of chlamydial origin.
MATERIALS AND METHODS
Bacterial strains and culture methods. C. trachomatis E/UW-5/CX (obtained from C. C. Kuo and S. P. Wang, University of Washington) was grown in McCoy cells and purified, and the titer was determined as described previously (33) . Reticulate bodies (RB) were purified by an adaptation of the endosome purification procedure of Matsumoto (31) followed by standard Renografin density centrifugation. The HEC-1B cell line used in screening and functional assays was propagated from a human endometrial adenocarcinoma (26) . McCoy and HEC-1B cells were cultured in Eagle's minimum essential medium (MEM) with 10% heat-inactivated bovine calf serum. E. coli JM109 [recAl endAl gyrA96 thi hsdRJ7 [rK-MK+] relAl supE44 A-A(lac-proAB) (F-traD36 proAB lacIqZVM15)] (53), JM109 (pUC19), and recombinants were grown at 37°C in Luria broth (LB) or on Luria plates with ampicillin (200 ,ug/ml) for plasmid-containing strains. Mid-log-phase bacteria were frozen in LB with 20% glycerol to generate freezer stock cultures.
Chiamydial DNA and plasmid preparation. Approximately 0.5 x 1010 to 5 x 1010 purified EB were used to isolate chlamydial genomic DNA as described previously (22) . Generally, the purified genomic DNA fragments were greater than 50 kb in length, as determined by electrophoresis in a 0.3% agarose gel. pUC19 (53) and recombinant plasmids were isolated from E. coli by the alkaline lysis method of Birnboim and Doly (2) and CsCl gradient centrifugation.
Creation of a C. trachomatis genomic library. The pUC19 vector was chosen because (i) a complete genomic library could be generated with <2,000 recombinants and (ii) pUC vectors were successfully used to isolate chlamydial genes encoding outer membrane proteins and an enzyme which were stably expressed and functional, respectively, in E. coli (5, 34) . A partial Sau3AI digest of C. trachomatis serovar E DNA was size fractionated on a 0.7% agarose gel. Fragments of 5 to 12 kb in length were electroeluted and ligated into pUC19, which had been digested with BamHI and then dephosphorylated with calf alkaline phosphatase. Strain JM109 was made competent for transformation by the rubidium chloride method of Hanahan (13) . Aliquots of the ligation reaction mixes were incubated with competent JM109 for 30 min on ice, then heated for 2 min at 42°C, and incubated for 90 min at 37°C. The bacteria were plated on LB plates containing ampicillin (100 ,ug/ml) and X-gal (5-bromo-4-chloro-3-indolyl-p-D-galactoside) (20 ,ug/ml) and incubated for 16 h at 37°C. Recombinant colonies were selected on the basis of insertional inactivation of the alpha fragment of 3-galactosidase on the plasmids, as determined by using the lactose analog X-gal. The vector, pUC19, did not require induction of the lac promoter (lacZp) by IPTG (lactose analog; isopropyl-1-thio-D-galactoside) to distinguish an active alpha fragment in the presence of X-gal. Apparently, the lac repressor does not completely stop transcription from lacZp on a high-copy-number plasmid such as pUC19. The chlamydial genomic library consisted of a total of 1,600 white colonies (,-galactosidase negative), which has a >99% probability of being complete if the chlamydial genome size is 1,450 kb (8) . Each recombinant was inoculated into a well of a 96-well microtiter plate containing LB and ampicillin and incubated overnight without agitation in a wet box at 37°C; glycerol was added to 25% before the entire microtiter plate was frozen.
Whole-cell screen. Our whole-cell screening technique is a modification of the technique used successfully by Isberg and Falkow (17) to identify the Yersinia pseudotuberculosis invasin gene. The recombinant E. coli clones which constitute the chlamydial library were assayed individually for adherence to eukaryotic cells. All recombinant JM109 and control strains were inoculated directly from freezer stocks into LB containing ampicillin (500 ,ug/ml) and incubated with 15 min, in accordance with the procedure used in our laboratory for chlamydial infections (16, 33 (31) , and the radiolabeled eukaryotic membranes were isolated on Percoll gradients (density, 1.05 g/ml). Following velocity centrifugation at 100,000 x g for 1 h at 4°C, the purified, radiolabeled membranes were suspended in phosphate-buffered saline containing 0.5% 3- (28 (29) , except the plasmid probes were labeled with dUTP-biotin by the random primer method (7) . After the standard hybridization procedure at 65°C (29) , the biotinylated probes were detected by using a streptavidin-alkaline phosphatase conjugate (24) .
Curing the plasmid. To determine whether loss of the adherent phenotype could be correlated with loss of the recombinant plasmid before further characterization and subcloning proceeded, the recombinant plasmid was cured from the host E. coli by transformation into the same strain of a second plasmid, pHSS6 (Kanr [38] ), incompatible with pUC19. The pHSS6 plasmid carries different selectable markers than pUC19; therefore, under only kanamycin selection, pHSS6 will supplant the Apr recombinant plasmid after many generations. pHSS6 was transformed into the recombinant strains (JM109) by electroporation (1) . The new transformants were initially selected on LB plates supplemented with ampicillin (200 ,ug/ml) and kanamycin (50 ,ug/ml). Subsequently, several transformants were chosen, grown to lag phase in LB broth containing only kanamycin (50 were washed, starved for 60 min at 37°C in M9 medium without casamino acids, and subsequently incubated at 37°C with either 25 ,uCi of Tran35S-label (ICN Biochemicals) or 25 ,uCi of '4C-mixed amino acids (New England Nuclear) for 1 or 4 h, respectively, to label newly synthesized proteins. The maxicell products were resolved by SDS-PAGE. Following fluorographic enhancement with Enlightening (New England Nuclear) radiographic enhancer for 15 min, the gels were dried (except for 20% polyacrylamide gels) and examined by autoradiography with X-ray film (X-OMAT AR; Eastman Kodak).
Production of polyclonal antisera and Western immunoblot analysis. C. trachomatis serovar E antisera were generated in female New Zealand White rabbits weighing 7 to 7.5 lb (ca. 3 to 3.4 kg). A Renografin-purified preparation of serovar E EB served as one inoculum, and EB which had been freshly treated with 10 mM dithiothreitol (DTT) in 2x sucrose-phosphate-glutamine buffer (2SPG) for 60 min at 37°C were used as a separate inoculum. DTT reduction was used to expose subsurface components perhaps masked by the tightly disulfide-bonded EB envelope. On examination by Macchiavello stain, the DTT-treated EB appeared blue, like RB (12) . Both preparations were suspended in 2x sucrose-phosphate-glutamine buffer to a final concentration of 109 EB per inoculum. The immunization schedules involved six initial intravenous injections over a 2-week period, followed by monthly subcutaneous boosts over a 6-month period. The polyclonal sera were collected approximately 10 days after each subcutaneous boost.
Following SDS-PAGE, protein was electrophoretically transferred to nitrocellulose (0.2-jim pore size; Schleicher & Schuell) as described by Towbin et al. (46) . Prior to blotting, antichlamydial antisera were adsorbed five times against JM109(pUC19) whole cells to reduce background crossreactive epitopes and subsequently diluted 1:200 in phosphate-buffered saline plus 0.05% Tween 20. An alkaline phosphatase-conjugated anti-rabbit immunoglobulin G (IgG; Sigma Chemical Co.) was used for Western detection as described by Blake et 
al. (3).
Monospecific, polyclonal antiserum against the -82-kDa protein was generated in a female New Zealand White rabbit. Total E. coli JM109(pPBW58) protein was resolved by preparative 8% polyacrylamide SDS-PAGE and visualized by staining with Coomassie brilliant blue, and the -82-kDa band was excised. Protein was eluted from the gel slices into 1 M NaCl with an electrophoretic concentrator (LKB 2014 Extraphor; Pharmacia-LKB), dialyzed extensively against 10 mM potassium phosphate buffer (pH 7.0, 4°C), lyophilized, and stored in 5% (wt/vol) sucrose at -70°C. The preparation contained no detectable level of lipopolysaccharide (LPS) as determined by the 2-keto-3-deoxyoctulosonic acid microassay of Karkhanis et al. (20) and was diluted in saline prior to injection. Two intravenous injections, each containing 51 jig of protein, were administered on days 1 and 5. Subsequent subcutaneous injections of 34 jig of protein, in Freund's incomplete adjuvant, were administered twice weekly beginning on day 15. The IgG fraction was purified from collected immune serum with a Rec-protein G affinity column (Zymed Laboratories, Inc.), adsorbed against E. coli JM109(pUC19), and diluted 1:1,000 for Western blot analysis as described above.
TEM. The procedures for preparation of samples for transmission electron microscopy (TEM), embedding in Epon-Araldite resin, and staining of the ultrathin sections were the same as described previously (52) . The sections were examined on a Philips 201 electron microscope operating at 60 kV.
RESULTS
Whole-cell screen. A functional screening method was used to identify possible chlamydial adherence determinants from a genomic library by testing whether the presence of expressed chlamydial genes inserted into pUC19 could make a nonadherent E. coli strain adhere to eukaryotic cells. Examination of Giemsa-stained infected monolayers by light microscopy ( Fig. 1 ) allowed us to pay particular attention to the pattern of attachment of the adherent bacteria. For any recombinant to be considered adherent, it had to be attached to the eukaryotic cells and not to the plastic surface of the culture vessel, and an average of .5 bacteria had to be attached per eukaryotic cell. These criteria were determined by assessing the attachment patterns of a positive control, piliated E. coli ORN 115 (Fig. 1A) , and of the negative control, JM109(pUC19), which rarely if ever attached (Fig.  1B) . Although attachment of the piliated E. coli is mediated by a different mechanism than that in the nonpiliated recombinants, the attachment pattern of a known adherent E. coli strain served to define the criteria for distinguishing true adherence from "nonspecific trapping."
Of the 1,600 recombinants screened individually on McCoy cells, 30 to 40 recombinants were initially recorded as positive. Following a second screening, 25 recombinants were selected for further screening on the human endometrial epithelial cell line HEC-1B. The level of adherence increased in nine of these recombinants to an average of 10 to 15 bacteria per HEC-1B cell (Fig. 1C and D) . The adherent recombinants were notably concentrated at the leading lamellapodial edge and thin processes of eukaryotic cells (Fig. IC) . Often there were large clusters of adherent bacteria on a single eukaryotic cell. We believed that this might be a eukaryotic cell cycle phenomenon for two reasons. All inocula had been carefully examined prior to addition to the monolayers, and clumping of the bacteria was not observed. Second, although the bacteria were in log phase, preliminary experiments had demonstrated that no appreciable bacterial cell division occurred during the adherence period when serum was omitted from the medium. Examination by TEM (Fig. 2) demonstrated that some recombinant E. coli were attached to indented electrondense regions of the polarized epithelial plasma membrane, which resemble coated pits (Fig. 2D) , but none appeared to be wholely within the cytoplasm.
Do the adherent recombinants enter epithelial cells? A standard invasion assay with gentamicin is based on the premise that the antibiotic does not readily penetrate eukaryotic cells. Therefore, gentamicin-sensitive bacteria are protected only if they have invaded eukaryotic cells. Initial results from the gentamicin assay found survivors of all adherent recombinant strains tested, suggesting that all were capable of invading the epithelial cells. However, TEM examination demonstrated that the bacteria were located in protected, extracellular niches, in between and underneath epithelial cells (data not shown). When the invasion assay was modified by adding gentamicin to a suspension culture of the infected epithelial cells, there were no survivors. Thus, none of the adherent recombinants appeared to enter the host cell.
Membrane-binding screen. An alternative screening method was undertaken to expose putative chlamydial adhesins which may not have been properly assembled on the surface of E. coli, as required in the whole-cell screen. This approach involved permeabilization of the membrane of the recombinant E. coli with CHC13 and subsequent incubation with radiolabeled eukaryotic membranes. Crude preparations of McCoy cell membranes were solubilized in several different detergents: Triton X-100, octylglucoside, and CHAPS. Comparison of the signals from the positive control, C. trachomatis serovar E EB, and the negative control, JM109(pUC19), demonstrated that CHAPS gave the best signal-to-background ratio. In addition, the divalent cations Ca2" and Mg2" were necessary for maximum signal. The entire library was screened with intrinsically 35S-labeled McCoy cell membranes and subsequently with 35S-labeled HEC-1B membranes, and five recombinants were considered to be positive (Fig. 2F) .
Only two recombinants were clearly positive by both screening methods, but this was not surprising since the location of expressed chlamydial adherence determinants in different E. coli compartments may affect binding function. The whole-cell screen appeared to be the more sensitive approach but was dependent on outer membrane localization and proper configuration of chlamydial gene products in E. (Fig. 4A,  lane 3) . It is presently difficult to designate an accurate molecular mass for the large polypeptide; it often migrates as a doublet and is susceptible to proteolytic breakdown. JM109(pPBW58) is reproducibly adherent by both screening assays, whereas JM109(pPBW57) (Fig. 4, lane 4) exhibits only minimal adherence in the whole-cell assay and produces only a 55-kDa protein. Unlike the 28-and -82-kDa proteins, which are consistently produced at a high level of expression, the appearance of the 55-kDa protein is often difficult to reproduce. Continued examination revealed that production of this protein varies with growth conditions, such as temperature, nutrient source, phase of growth, and ampicillin concentration. For example, the first four lanes of Fig. 4A are from E. coli grown in the presence of 200 ,ug of ampicillin per ml; the last two lanes show E. coli grown in the presence of 500 ,ug of ampicillin per ml. The higher (B) were generated against C. trachomatis serovar E EB (anti-EB) or EB pretreated with 10 mM DTT (anti-EB-DTT).
concentration of ampicillin resulted in production of a 55-kDa protein in the host E. coli JM109(pUC19) (Fig. 4A, lane  5) . Therefore, the 55-kDa protein appears to be an E. coli protein and is perhaps involved in stress response. We recognize that production of this protein may contribute to minimal levels of nonspecific attachment in the whole-cell screen; however, (i) JM109(pUC19) grown in the presence of ampicillin (500 Fxg/ml) is consistently nonadherent and (ii) JM109(pPBW58) is consistently adherent regardless of the presence or absence of abundant 55-kDa protein. Following exposure to chloroform, JM109(pPBW56) (Fig. 4A, lane 6 ) exhibits a striking affinity for eukaryotic membranes but is nonadherent in the whole-cell screen. The presence of an 18-kDa protein is consistently observed, although at a lower level of production relative to the 28-kDa and -82-kDa proteins.
Selected recombinants were examined further for recognition of novel proteins by C. trachomatis serovar E polyclonal antisera (Fig. 4B) . One antiserum was generated against EB, and the other antiserum was generated against EB pretreated with DTT (anti-DTT-EB antiserum) to expose subsurface components that may be masked by the tightly disulfide-bonded EB envelope. The -82-kDa protein is strongly recognized by both antisera [E. coli JM109 (pPBW58), Fig. 4B, lanes 2 and 5) , but the 28-kDa protein is detected only by the anti-DTT-EB antiserum (lane 5). As expected, the 55-kDa protein is not reactive against these preadsorbed antisera. E. coli JM109(pPBW58) also produces an 18-kDa protein which is recognized only by Western blotting with anti-EB serum (Fig. 4B, lane 2) The antigenic recognition of the 18-, proteins by chlamydial antisera is encouraging, but to ascertain their origin from chlamydial gene sequences, maxicell analyses were conducted with E. coli JM109 recombinants carrying pPBW56 and pPBW58 (Fig. 5) . With Tran35S-label (70% 35S-labeled methionine and 15% 35S-labeled cysteine [ICN Biochemicals]; Fig. SA) , it is clearly evident that the 28-and -82-kDa proteins originate from the chlamydial plasmid inserts (lanes 1 and 2) . There are some additional bands, particularly a 35-kDa protein from E. coli JM109 (pPBW56) (Fig. 5A, lane 4) , which are not detectable by Coomassie stain or Western blot. The 43-kDa band visualized in E. coli JM1O9(pPBW58) maxicells most likely represents a specific proteolytic cleavage product of the -82-kDa protein; radioanalytic imaging and analysis (Ambis) of repetitive experiments consistently show that the amount of the 43-kDa protein coincides quantitatively with the amount of -82-kDa protein produced.
Since some plasmid-encoded proteins may be Met and Cys deficient, the maxicell analysis was also conducted with a mixture of 14C-L-amino acids (Fig. SB) . E. coli JM109 (pPBW58) (lanes 1 and 2) shows intense signals for the 28-kDa and -82-kDa proteins, and a weak signal is detectable in the 18-kDa migrational range. Convincing evidence of plasmid origin for the 18-kDa protein(s) awaits sequence analyses, which are currently in progress.
To address the possibility that the expressed proteins might originate from gene fusions, more-specific antibody INFECT. IMMUN. and nucleic acid probes are being generated. Particular emphasis is given to the newly described high-molecularmass protein. Monospecific antiserum was generated against the -82-kDa protein from JM1O9(pPBW58), eluted from SDS-PAGE gels. As shown in Fig. 6 , the antiserum specifically recognizes a protein of similar size in highly purified C. trachomatis serovar E EB and RB (Fig. 6B, lanes 3 and 4) , lymphogranuloma venerum serovar L2 (lane 5), and C. psittaci Cal-10 (lane 6). Curing the plasmid. Although the whole-cell screen was conducted on the freshly generated recombinant library (three passages in broth culture), one early observation for E. coli JM1O9(pPBW58) was that a combination of multiple passages and freeze-thaw cycles resulted in decreased percentages of the adherent population and much lower expression of the 28-and -82-kDa proteins [E. coli JM109 (pPBW58*), Fig. 5A and B]. Plasmid preparations do not indicate the presence of a contaminating plasmid. It is presently unclear whether this represents some type of transcriptional or translational regulation that reduces the level of expression of the chlamydial proteins, but a correlation between adherence to whole cells and the amount of recombinant protein produced is evident. The addition to log-phase E. coli JM1O9(pPBW58) cultures of 1 mM isopropylthiogalactoside, which induces the lac promoter, has no obvious effect on the level of expression of the 28-or -82-kDa protein.
Two methods were used to link the adherent phenotype of recombinant JM1O9(pPBW58) with the presence of the plasmid pPBW58. In the first method, pPBW58 was cured from the recombinant, with concomitant loss of the adherent phenotype. The original recombinant was transformed with pHSS6, which is incompatible with pPBW58; selection for pHSS6 (Knr) resulted in loss of pPBW58 from the strain as well as loss of the ability to attach to epithelial cells. In the second method, the purified plasmid pPBW58 was reintroduced by electroporation into E. coli JM109; recombinant progeny had acquired the adherent phenotype and produced 28-and -82-kDa proteins at levels comparable to those in the original recombinant.
Further analysis of recombinant E. coli JM109(pPBW58). Recombinant E. coli JM1O9(pPBW58) is an obvious candidate for additional studies for several reasons: (i) it is consistently positive in both binding assays, which correlates with the presence of the plasmid; (ii) it contains a large chlamydial insert (6.7 kb); and (iii) it produces -82-and 28-kDa recombinant chlamydial proteins, and possibly one of 18 kDa, the relative amounts of which are reduced in nonadherent variant strains. E. coli JM1O9(pPBW56), which is only positive in the membrane-binding assay, also contains a large insert of 5.8 kb, but may be deficient in the ability to accommodate chlamydial proteins in a native, functional form. Restriction mapping to date shows little to no identity between pPBW56 and pPBW58, providing some support to the possibility of having cloned two separate genes encoding 18-kDa proteins.
Recognizing that the nonspecific stickiness of E. coli recombinants expressing chlamydial gene products could be a major factor in the results of the screening assays, the binding of recombinant JM1O9(pPBW58) to presence of the polyanion dextran sulfate, (iv) reduced adherence on exposure of the bacteria to trypsin (10 jig/ml), (v) no change in adherence when the bacteria are rendered nonviable by sodium azide (0.02%) treatment for 15 min at 37°C, and (vi) adherence to rabbit aortic endothelial cells. In all cases, the binding specificity of JM109(pPBW58) paralleled that of C. trachomatis, whereas the binding of the positive control, piliated E. coli ORN 115, did not mimic the pattern of C. trachomatis binding in every instance. In addition, previous studies in our laboratory with primary human endometrial gland epithelial cells (HEGEC) have shown a differential susceptibility to chlamydial adherence which appears to be modulated by hormone exposure (30) . Tissue obtained from patients in the proliferative phase (estrogen dominant), maintained in medium containing physiological concentrations of estrogen, was able to attach significantly greater numbers of chlamydiae than secretory-phase (progesterone dominant) tissue. Binding of JM109(pPBW58) to each hormone-responsive cell type has been examined in one experiment to date. There was essentially no difference in the numbers of recombinant bacteria adherent to estrogen-dominant HEGEC and progesterone-dominant HEGEC on a per-microscope-field basis, even though the cell density of estrogen-dominant HEGEC was less than that of progesterone-dominant HEGEC. However, the pattern of distribution of adherent bacteria was strikingly different. At least five or more JM109(pPBW58) cells were bound to susceptible estrogen-dominant HEGEC, whereas essentially only one bacterium was attached to susceptible progesterone-dominant cells. JM109(pPBW58) in suspension and attached to HEC-1B cells was analyzed by indirect immunofluorescence with polyclonal anti-EB or anti-DTT-EB antibodies and then with fluorescein isothiocyanate-conjugated, second-affinity goat anti-rabbit IgG antiserum. There was no obvious specific labeling of the recombinant E. coli surface even though the bacterial outer membrane was perturbed by EDTA and exposed to lysozyme. It is possible that chlamydial proteins are masked by E. coli components, such as LPS, and/or that the interaction with the epithelial cell surface triggers exposure of functional epitopes. Alternatively, the antichlamydial antisera may not contain antibodies against surface-accessible epitopes. It should be noted that the polyclonal antichlamydial antisera used in these studies do not block adherence of infectious EB to target host cells. An initial experiment (data not shown) in which the inner and outer membrane of E. coli were separated by isopycnic sucrose gradient centrifugation (a modification of the method of Ito et al. [18] ) indicates that the -82-kDa protein is present in the outer membrane. The 28-and 18-kDa proteins appear to be associated with whole membrane prior to separation; however, the extent of this association, particularly in the presence of EDTA, is presently not clear and is under further investigation. DISCUSSION C. trachomatis is an adept bacterial parasite, as demonstrated by its high incidence in humans. In the United States, C. trachomatis genital infection is considered the most prevalent sexually transmitted disease, and in developing countries, C. trachomatis eye infection affects an estimated 500 million people. As an intracellular pathogen, infectious chlamydial EB must attach to and enter host cells to successfully initiate infection. How does a nonmotile, nonpiliated, negatively charged, metabolically inert EB adhere to host cells?
Lacking motility, chlamydiae must rely on Brownian motion and fluid currents to carry them to the host cell. TEM observations have suggested that Chlamydia spp. initially attach to the tips of microvilli, move down the length of the microvilli, and are internalized at the apical surface of the epithelial cell. The initial association with the tips of the microvilli is probably a consequence of reduced electrostatic repulsion between the negatively charged EB and the negatively charged yet small-diameter microvillus tip, compared with the relatively large expanse of negative charge found at the apical surface of the host cell (49) . Originally, Hatch et al. (14) proposed that electrostatic interactions mediate the binding of chlamydiae to host cells. Subsequently, Ward (49) proposed that attractive nonspecific forces, hydrophobic interactions, and London-van der Waals forces compete with repulsive electrostatic interaction between the negatively charged surfaces of the EB and eukaryotic cell. The effect of electrostatic repulsion between the EB and the host cell surface may be reduced in the presence of divalent cations, such as Ca2" and Mg2" (14) , and polycations, such as DEAE-dextran (25), more so for the more negatively charged C. trachomatis serovars A through K than for the LGV serovars (39) . Indeed, in a recent study by Su et al. (44) , negatively charged divergent sequences in exposed MOMP variable domains II and IV were suggested to function by electrostatic interactions in the initial binding of C. trachomatis serotype B to Syrian hamster kidney cells. Monoclonal antibody binding to the two domains significantly blocked attachment of chlamydiae to the host cells, presumably by interfering with the charge-dependent interactions (43, 44) . According to the authors, a conformational change then occurred in the invariant nonapeptide sequences in variable domain IV, resulting in the exposure of a more specific, cryptic, hydrophobic binding site. Since these binding studies were performed on Syrian hamster kidney cells rather than on the HeLa 229 cells in which the chlamydiae stocks were grown, there may be differences in the net negative charges as well as other surface properties between different epithelial cell types. An example of this possibility was noted in studies in our laboratory with primary human endometrial gland epithelial cells (HEGEC [30] ), in which two populations of epithelial cells were distinguished by the fluorescence activated cell sorter; the one to which C. trachomatis serovar E bound possessed numerous microvilli and no obvious extracellular matrix; the second population, to which the chlamydiae did not bind, were devoid of microvilli and covered with a dense glycocalyx. Our failure to identify positive recombinants expressing MOMP by the functional screening assays might also be explained by the difficulty, reported by other investigators, of isolating recombinant E. coli expressing high levels of chlamydial MOMP (42) .
Once electrostatic and hydrophobic interactions have drawn the chlamydiae close (-2 to 9 nm) to the target host cell, do other interactions involving additional chlamydial adherence determinants occur, such as specific intermolecular interactions (cl nm) between adhesins and receptors? Kihlstrom and Majeed (23) have recently reported that C. trachomatis EB first attach diffusely over the host cell but are mobilized into clusters before they are internalized. This observation is reminiscent of Fc receptor-mediated antibody capping on B-lymphocytes as well as receptor clustering into coated pits; the latter is part of the process of receptormediated endocytosis, which has been implicated in chlamydial uptake (15, 16, 36, 40) . If movement of chlamydiae along the host cell membrane is caused by the directed movement of a eukaryotic receptor within the apical membrane, it follows that C. trachomatis EB may have a specific adhesin(s). Although many of the chlamydial genes which had been isolated in E. coli have been identified by assaying for expression of the gene product with antichlamydial antisera, antiadhesin antibody has not been found. Thus, we used functional screening methods to identify putative adherence determinant gene products in recombinant E. coli clones.
These screening methods have identified several recombinants which bind eukaryotic membranes. However, recombinants that were adherent in the whole-cell screen could have their surface properties, such as charge or hydrophobicity, altered by the presence of foreign chlamydial proteins in their outer membrane. For instance, the recombinant E. coli which produces a chlamydialike LPS associates with HeLa cells two to five times more than the parental strain. Strains of E. coli lacking the LPS 0 antigen side chain demonstrate greater association with intestinal mucosa (35, 50) . Likewise, recombinants positive for the membrane-binding blot may produce chlamydial proteins that have nonspecific membrane affinity. Chlamydial polypeptides of 18 and 27 to 32 kDa (the size of the latter depending on the serovar), after boiling in SDS, separation by SDS-PAGE, and electrophoretic transfer to nitrocellulose, were shown to bind to isolated, radioiodinated HeLa cell membranes. These proteins were purportedly involved in adherence (10, 21, 51) .
Recently, the genes encoding the 18-kDa proteins have been cloned and sequenced. One gene product has predicted amino acid homology with eukaryotic histone Hi, and the encoded protein has a calculated pl of 11.4 (11) . The other gene appears to contain a fusion between two noncontiguous regions of genomic DNA, and the amino terminus of the fusion is a chlamydial homolog of the E. coli ribosomal protein L6 gene (9) . Such proteins may have bound the iodinated membrane via nonspecific electrostatic interactions (11) or, alternatively, may have bound to nucleic acid still associated with the eukaryotic membranes. Though some of our positive recombinants are producing novel proteins of a similar size, the novel proteins do not appear to be homologous to the chlamydial histone Hi-like protein, the ribosomal L6-like protein, or the 27-to 32-kDa protein.
Monoclonal antiserum generated against the 27-to 32-kDa protein and polyclonal serum generated against purified 18-kDa (Hcl) protein (courtesy of T. Hackstadt) did not react with novel proteins produced by JM109(pPBW56) or JM109(pPBW58). Likewise, antiserum generated against the ribosomal L6 homolog did not react with novel proteins produced by our recombinants, nor did the chlamydial insert of pCT161/18 (both courtesy of W. Wenman) containing the ribosomal L6 gene homolog hybridize with our recombinant plasmids (pPBW56 and pPBW58) on a Southern blot. Furthermore, a polyclonal antiserum which reacts strongly with MOMP did not react with either JM109(pPBW56) or JM109 (pPBW58). It appears that we may have identified different chlamydial proteins which may function in chlamydial adherence. Yet the question still remains: are these novel chlamydial proteins synthesized in E. coli mediating a specific or nonspecific interaction with eukaryotic membranes?
The increased signal and selectivity demonstrated by our positive recombinants when HEC-1B epithelial cells replaced McCoy cells in the screening assay suggest a certain specificity of the association. Also, the binding specificity of JM109(pPBW58) to HEC-1B cells and hormone-responsive primary HEGEC, which parallels that of C. trachomatis, is very suggestive of specificity.
The significance of the lack of internalization of the strongly adherent recombinants is not understood at this time. Assuming that these recombinants do express chlamydial adherence determinants, a number of explanations are possible, including (i) chlamydiae have several different adhesins, of which a subset triggers internalization; (ii) the mechanism of internalization of chlamydiae is size-restricted, excluding the larger E. coli; (iii) the "adhesin" density on the surface of E. coli is not great enough to trigger internalization; and/or (iv) possibly some enzymatic action occurring after adherence is required for internalization. Clearly, before any chlamydial gene products are described as adhesins, experiments other than those which establish some unspecified role in attachment are necessary to demonstrate that the proteins mediate specific interactions with epithelial cell receptors.
